Abingworth as of Dec. 31, 2018
Portfolio Holdings for Abingworth
Abingworth holds 16 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 30.4 | $34M | 1.2M | 28.57 | |
| Sientra | 25.4 | $28M | 2.2M | 12.72 | |
| Verona Pharma Plc ads (VRNA) | 7.4 | $8.1M | 902k | 9.00 | |
| Soleno Therapeutics | 7.2 | $8.0M | 4.7M | 1.71 | |
| Chiasma | 5.5 | $6.1M | 2.1M | 2.93 | |
| Obseva Sa | 5.1 | $5.6M | 440k | 12.65 | |
| Paratek Pharmaceuticals | 4.8 | $5.3M | 1.0M | 5.13 | |
| Proteon Therapeutics | 4.2 | $4.6M | 2.0M | 2.27 | |
| Aurinia Pharmaceuticals (AUPH) | 2.5 | $2.7M | 400k | 6.80 | |
| Sierra Oncology | 1.7 | $1.9M | 1.4M | 1.31 | |
| Cellectis S A (CLLS) | 1.5 | $1.7M | 100k | 16.64 | |
| Ultragenyx Pharmaceutical (RARE) | 1.5 | $1.7M | 38k | 43.46 | |
| Adaptimmune Therapeutics (ADAP) | 1.3 | $1.4M | 250k | 5.75 | |
| Cymabay Therapeutics | 0.9 | $1.0M | 131k | 7.86 | |
| Immune Design | 0.4 | $458k | 352k | 1.30 | |
| Histogenics Corp Cmn | 0.1 | $80k | 889k | 0.09 |
